Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro IV: Implications for the development of agranulocytosis
- 7 October 1994
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 48 (7), 1349-1354
- https://doi.org/10.1016/0006-2952(94)90556-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro—II: Movement of dapsone across a semipermeable membrane into erythrocytes and plasmaBiochemical Pharmacology, 1993
- Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitroBiochemical Pharmacology, 1993
- The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Ideosyncratic Drug ReactionsDrug Metabolism Reviews, 1992
- Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.British Journal of Clinical Pharmacology, 1989
- Metabolism of procainamide to a hydroxylamine by human neutrophils and mononuclear leukocytesChemical Research in Toxicology, 1988
- Clinical Pharmacokinetics of DapsoneClinical Pharmacokinetics, 1986
- In Vitro Inhibition of Granulopoiesis by 4-Amino-4'-Hydroxylaminodiphenyl SulfoneBritish Journal of Haematology, 1980
- Compound I of myeloperoxidaseBiochemical and Biophysical Research Communications, 1980
- ADVERSE EFFECTS OF DAPSONEInternational Journal of Dermatology, 1975
- Microsomal N-Oxidation of Dapsone as a Cause of Methemoglobin Formation in Human Red Cells *The American Journal of Tropical Medicine and Hygiene, 1972